These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30838740)

  • 1. Can serum level of N-terminal pro B-type natriuretic peptide be used in patients with psoriasis as a predictor of cardiovascular disease?
    Shahidi-Dadras M; Niknezhad N; Niknejad N; Zargari O
    Dermatol Ther; 2019 May; 32(3):e12865. PubMed ID: 30838740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum level of N-terminal Pro-B-type natriuretic peptide as a possible biomarker of cardiovascular risk in psoriatic patients.
    Pietrzak A; Bartosinska J; Blaszczyk R; Chodorowska G; Brzozowski W; Hercogova J; Donica H; Lotti T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):1010-4. PubMed ID: 24735175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
    Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
    Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
    Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
    Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.
    Suthahar N; Meijers WC; Ho JE; Gansevoort RT; Voors AA; van der Meer P; Bakker SJL; Heymans S; van Empel V; Schroen B; van der Harst P; van Veldhuisen DJ; de Boer RA
    Eur J Heart Fail; 2018 Aug; 20(8):1205-1214. PubMed ID: 29855124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity.
    Fernandes F; Ramires FJ; Buck PC; Almeida IJ; Rabelo R; Dantas SA; Salemi VM; Halpern A; Mady C
    Braz J Med Biol Res; 2007 Feb; 40(2):153-8. PubMed ID: 17273651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-B-type natriuretic peptide (NT-proBNP) assessment in the first year after renal transplantation and its relationship with graft function and left ventricular hypertrophy.
    Slubowska K; Sadowska A; Kwiatkowski A; Durlik M
    Transplant Proc; 2014 Oct; 46(8):2729-32. PubMed ID: 25380904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    Hypertension; 2005 Oct; 46(4):660-6. PubMed ID: 16129819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index.
    Hong SN; Ahn Y; Yoon NS; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Int Heart J; 2008 Jul; 49(4):403-12. PubMed ID: 18753724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.
    Eggers KM; Lindahl B; Venge P; Lind L
    Int J Cardiol; 2018 Apr; 257():300-305. PubMed ID: 29506712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide and cardiovascular function in young children with obstructive sleep apnea.
    Goldbart AD; Levitas A; Greenberg-Dotan S; Ben Shimol S; Broides A; Puterman M; Tal A
    Chest; 2010 Sep; 138(3):528-35. PubMed ID: 20558551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease.
    Dallmeier D; Pencina MJ; Rajman I; Koenig W; Rothenbacher D; Brenner H
    PLoS One; 2015; 10(1):e0117143. PubMed ID: 25629613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic position is associated with N-terminal pro-brain natriuretic peptide (NT-proBNP)-Results of the population-based Heinz Nixdorf Recall study.
    Rudman M; Frank M; Emmel C; Matusch E; Kara K; Mahabadi AA; Erbel R; Jöckel KH; Dragano N; Schmidt B
    PLoS One; 2021; 16(8):e0255786. PubMed ID: 34415953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.